Neurizon Therapeutics LimitedASX: NUZ

Appendix 4C & Quarterly Update

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 10 pages · English

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Quarterly Report & Appendix 4C: Q4 FY26 Highlights: Clinical and preclinical development activity · HEALEY ALS...

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases